Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages

Phase 2

Completed

Conditions: Paranasal Sinus Cancer
Nasal Cavity Tumor
Nasal Cavity Adenocarcinoma

Interventions: Drug: Cisplatin
Radiation: Adjuvant Proton Radiotherapy
Procedure: Endoscopic Resection
Drug: cisplatin and etoposide

First Posted Date: 2017-09-07

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT03274414

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 2 locations

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Phase 3

Completed

Conditions: Pancreas Cancer
Pancreatic Diseases
Pancreatic Cancer

Interventions: Drug: Cefoxitin
Drug: Piperacillin-tazobactam

First Posted Date: 2017-09-01

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 958

Registration Number: NCT03269994

Locations: 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Hackensack Meridian Health / Hackensack University Medical Center Cancer Center, Hackensack, New Jersey, United States

and more 29 locations

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Phase 1

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: MR-based image-guided, intensity-modulated radiotherapy

First Posted Date: 2017-08-31

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT03269422

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only and follow up), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 4 locations

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Not Applicable

Recruiting

Conditions: Locally Advanced Breast Cancer
Breast Cancer

Interventions: Procedure: Sentinel Lymph Node Biopsy (SLNB)

First Posted Date: 2017-08-21

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 150

Registration Number: NCT03255577

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only and Follow Up), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 5 locations

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Recruiting

Conditions: Lymphedema

Interventions: Behavioral: Quality of Life Assessments

First Posted Date: 2017-08-14

Last Posted Date: 2025-05-31

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 600

Registration Number: NCT03248310

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States

A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer

Phase 1

Active, not recruiting

Conditions: High Grade Serous Ovarian
Fallopian Tube
Primary Peritoneal Cancer

Interventions: Drug: Carboplatin and Paclitaxel
Drug: Nivolumab
Procedure: Cytoreductive surgery
Drug: Ipilimumab

First Posted Date: 2017-08-10

Last Posted Date: 2025-04-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT03245892

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Phase 1

Active, not recruiting

Conditions: Pancreatic Adenocarcinoma

Interventions: Drug: Durvalumab
Radiation: Stereotactic Ablative Body Radiotherapy (SABR)

First Posted Date: 2017-08-10

Last Posted Date: 2024-10-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT03245541

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

and more 4 locations

A Study of Nivolumab in Selected Uterine Cancer Patients

Phase 2

Completed

Conditions: Uterine Cancer
Clear Cell Carcinoma
Endometrial Carcinoma
Carcinosarcoma
Leiomyosarcoma
Undifferentiated Sarcoma
High Grade Endometrial Stromal Sarcoma

Interventions: Drug: Nivolumab

First Posted Date: 2017-08-07

Last Posted Date: 2024-12-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT03241745

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 5 locations

Pembrolizumab (immunotherapy Drug) in Combination with Guadecitabine and Mocetinostat (epigenetic Drugs) for Patients with Advanced Lung Cancer.

Phase 1

Active, not recruiting

Conditions: Lung Cancer

Interventions: Drug: Pembrolizumab
Drug: Guadecitabine
Drug: Mocetinostat

First Posted Date: 2017-07-18

Last Posted Date: 2024-12-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT03220477

Locations: 🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2

Active, not recruiting

Conditions: Brain Tumor

Interventions: Drug: abemaciclib

First Posted Date: 2017-07-18

Last Posted Date: 2024-07-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT03220646

Locations: 🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States
🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only), Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy